A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: A source of cells for transplantation in Parkinson's disease

Experimental Neurology

Volumn 171, Issue 1, 2001, Pages 98-108

  Carvey, P M ^a   Ling, Z D ^a   Sortwell, C E ^a   Pitzer, M R ^a   McGuire, S O ^a   Storch, A ^b   Collier, T J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

6 hydroxydopamine; Glial cell line derived neurotrophic factor (GDNF); Interleukins; Leukemia inhibitory factor; Nurr1; Tissue culture

Indexed keywords

CYTOKINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; LEUKEMIA INHIBITORY FACTOR; NUCLEAR RECEPTOR RELATED FACTOR 1; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CORPUS STRIATUM; CRYOPRESERVATION; DISEASE MODEL; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RAT; ROTATION; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 0034845508     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7735     Document Type: Article

References (38)

1. Estimation of nuclear populations from microtome sections
2. Adenovirus in the brain: Recent advances of gene therapy for neurodegenerative diseases
3. Cell replacement therapies for central nervous system disorders
4. Survival of expanded dopaminergic precursors is critical for clinical trials
5. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: An argument for neurotrophic supplementation
6. The role of cytokines in the neuropathology of stroke and neurotrauma
7. Innovative treatment or ethical headache? Fetal transplantation in Parkinson's disease
8. Bilateral fetal nigral transplantation into the post-commissural putamen in Parkinson's disease
9. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain
10. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology
11. Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft
12. Using fetus-derived tissues for molecular medicine: Tension between research and ethics
13. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies
14. Dopaminergic transplants in patients with Parkinson's disease: Neuroanatomical correlates of clinical recovery
15. Update on fetal transplantation: The Swedish experience
16. Engineering neurons for Parkinson's disease
17. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines
18. Stem cells in the central nervous system
19. Progenitor cell biology: Implications for neural regeneration
20. Ontogenesis of embryonic porcine ventral mesencephalon in the perspective of its potential use as a xenograft in Parkinson's disease
21. Identification of L-dopa-dopamine and L-dopa cell bodies in the rat mesencephalic dopaminergic cell systems
22. Fetal nigral transplantation as a therapy for Parkinson's disease
23. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
24. Cytokine-induced DA neuron conversion: Comparing striatal and mesencephalic progenitor cells
25. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons
26. Isolation and manipulation of rostral mesencephalic tegmental progenitor cells from rat
27. In vivo magnetic resonance spectroscopy of human fetal neural transplants
28. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic dopaminergic precursor neurons
29. Transplantation of expanded mesencephalic precursors leads to recovery in Parkinsonian rats
30. Longterm survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease
31. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons
32. Stimulation of neuron survival by basic FGF and CNTF is a direct effect and not mediated by non-neuronal cells: Evidence from single cell cultures
33. Induction of a midbrain dopaminergic phenotype in Nurr1 over-expressing neural stem cells by type 1 astrocytes
34. Distribution of messenger RNAs for the orphan nuclear receptors and Nur77 (NGFI-B) in adult rat brain using in situ hybridization
35. Rat Nurr1 is prominently expressed in perirhinal cortex, and differentially induced in the hippocampal dentate gyrus by electroconvulsive vs. kindled seizures
36. Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives
37. Dopamine neuron agenesis in Nurr1-deficient mice